Intrahepatic cholangiocarcinoma: metformin & reduced risk

This study confirmed diabetes and smoking as independent risk factors for ICC. A novel finding was that treatment with metformin was significantly associated with a 60% reduction in ICC risk in diabetic patients (Hepatology)